Skip to content

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

RAIL FreightCar America, Inc.
$13.48 -0.55% -0.08
Notify me if price changes either direction
Interactive Brokers Logotype

Buy RAIL stocks now with Interactive Brokers – the most advanced investment platform

Contents
  • Performance
  • Key stats
  • Financials
  • US politician trades
Loading

Key Stats

Market cap. 257.8M
Enterprise value 363.9M
Trailing PE 5.166706
Forward PE 16.621473
PEG Ratio -0.055224971317365
Enterprise to EBITDA 8.361
Enterprise to revenue 0.709
Price to book MRQ -4.7266585792966
Price to sales TTM 0.48534614

Financials

Fiscal Year Ends 2024-12-31
Most Recent Quarter (MRQ) 2025-09-30
Revenue (TTM) 513.1M
EBITDA 47.6M
Diluted EPS TTM 2.52
Total Cash (MRQ) 62.2M
Current ratio (MRQ) 1.665
Operating Cash Flow (TTM) 30.6M

RAIL trades by the US politicians

Percentage
0% 0 sells
100% 0 buys
Amount
$0 0 sells
$0 0 buys
In the last 0 months

Recent RAIL News

Home

IMPORTANT NOTICE

Finbold is a news and information website. This Site may contain sponsored content, advertisements, and third-party materials, for which Finbold expressly disclaims any liability.

RISK WARNING: Cryptocurrencies are high-risk investments and you should not expect to be protected if something goes wrong. Don’t invest unless you’re prepared to lose all the money you invest. (Click here to learn more about cryptocurrency risks.)

By accessing this Site, you acknowledge that you understand these risks and that Finbold bears no responsibility for any losses, damages, or consequences resulting from your use of the Site or reliance on its content. Click here to learn more.